top of page
GSKURE (previously CerebraMed)
Gskure is an IP based company that owns innovative proprietary GSK-3 peptide inhibitors drug candidates. GSK-3 is related to varius neurodegenerative diseases
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
GSKURE (previously CerebraMed) | 03/09/2022 | NeuroPharmacology | NeuroBioTechnology | Biotechnology & Biopharmaceutical | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Biochemical: pharmacological drugs (Developing drugs) | 01/01/2016 | "1-10" |
The protein GSK-3 is a causative factor behind a broad spectrum of
neurodegenerative disorders. Inhibition of GSK-3 should limit the
progression of neurodegeneration and rescue pathological symptoms.
bottom of page